Loading data
BMRANasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 4.45 m USD | 5.31 m USD | 5.42 m USD | 5.34 m USD | 18.87 m USD |
| Cost of revenue | 4.09 m USD | 4.81 m USD | 4.8 m USD | 4.89 m USD | 15.89 m USD |
| Gross profit | 362 k USD | 498 k USD | 611 k USD | 446 k USD | 2.98 m USD |
| Research and development expense | 788 k USD | 1.02 m USD | 1.49 m USD | 1.58 m USD | 1.81 m USD |
| Selling, general and administrative expense | 4.89 m USD | 4.61 m USD | 5.49 m USD | 6.09 m USD | 5.7 m USD |
| Operating profit | -5.32 m USD | -5.14 m USD | -6.37 m USD | -7.22 m USD | -4.53 m USD |
| Profit before tax | -3.75 m USD | -4.97 m USD | -5.94 m USD | -7.09 m USD | -4.51 m USD |
| Income tax expense | 23 k USD | 1 k USD | 42 k USD | 51 k USD | 24 k USD |
| Net income (reported basis) | -3.78 m USD | -4.97 m USD | -5.98 m USD | -7.14 m USD | -4.53 m USD |
| Basic earnings per share | -1.3 USD/share | -2.16 USD/share | -2.84 USD/share | -0.5 USD/share | -0.36 USD/share |
| Diluted earnings per share | -1.3 USD/share | -2.16 USD/share | -2.84 USD/share | -0.5 USD/share | -0.36 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.